Research on the Treatment of Severe Community-acquired Pneumonia in Children
The need for glucocorticoid therapy in children with severe community-acquired pneumonia in the acute phase of the disease remains unclear. The implementation of this study could provide strong evidence on the need for adjuvant glucose therapy in children with severe community-acquired pneumonia.
• 1 month-\< 18 years old.
• Clinical diagnosis of community-acquired pneumonia (fever, cough, sputum, chest pain, dyspnea, abnormal breath sounds in the lungs, imaging pneumonia changes).
• Meet any of the following:
‣ (1) the general condition is very poor;
⁃ (2) refusal to eat or dehydration;
⁃ (3) Significantly increased respiratory rate (70 times/min \> infants, 50 times/min for older children\>);
⁃ (4) dyspnea (three concave sign, moaning, nasal flapping)
⁃ (5) hypoxemia (cyanosis, transcutaneous oxygen saturation\< 92% (not oxygenated));
⁃ (6) Pulmonary infiltration≥ 2/3 lung or multilobar infiltration;
⁃ (7) There is a pleural effusion;
⁃ (8) Extrapulmonary complications